News and Comments

PROSENSA: BACK INTO THE LIMELIGHT

  Tuesday, March 18, 2014

Prosensa Holding N.V. (RNA) might have good news that was made possible through insightful observation following past results that almost condemned the Dutch biopharmaceutical company’s compound drisapersen for the treatment of Duchenne Muscular Dystrophy (DMD).  More...


Recent Postings


Archive


Tags

Vertex (VRTX) Bristol-Myers Squibb (BMY) ABBVIE (ABBV) Xoma (XOMA) Human Longevity (HLI) Jazz Pharmaceuticals (JAZZ) REGULUS (RGLS) HALOZYME (HALO) Illumina (ILMN) VANDA (VNDA) AERIE PHARMACEUTICALS Ariad (ARIA) Dendreon (DNDN) ACADIA (ACAD) Theravance (THRX) Array Pharmaceuticals (ARRY) Prosensa (RNA) Spike Therapeutics (ONCE) Ziofpharm (ZIOP) Tysabri Dynavax (DVAX) Roche (RHHBY) C4 Therapeutics Idenix (IDIX) Adaptimmune (ADAP) galapagos (GLPG) Intermune (ITMN) CompuGen (CGEN) Agenus (AGEN Global Cell Therapeutics (GBT) KITE (KITE) Sanofi (SNA) Mirati Therapeutics (MRTX) Sanofi (SNY) SERES THERAPEUTICS (MCRB) NEKTAR (NKTR)) NANTKWEST (NK) Biocryst (BCRX) Aimmune Therapeutics (AIMT) Abbott Laboratories (ABT) Amgen (AMGN) ARCA (ABIO) Intrexon (XON) JOUNCE THERAPEUTICS (JNCE) RenenxBio (RGNX) Micromet (MITI) Sanofi-Aventis (SAN) Gilead (GILD) Sangamo (SGMO) MODERNA Ridaforolimus AGOS (ARGS) Intercept (ICPT) AstraZeneca (AZN) Regeneron (REGN) Cytokinetics (CYTK) Trastuzumab-DM1 Alnylam (ALNY) Biogen Idec (BIIB) OSI (OSIP) Rapamune Genentech ISIS (ISIS) Vitae Pharmaceuticals (VTAE) Endometrial Cancer Onyx (ONXX) Agenus (AGEN) Inovio (INO) Benlysta (belimumab) Ionis (IONS) Roche (ROCHE) Seattle Genetics (SGEN) GUARDIAN HEALTH INNOVIVA (INVA) Multiple Myeloma Prolor Biotech (PBTH) Merck (MRK) Revlimid (lenolidamide) Pluristem (PSTI) Auspex (ASPX) GlaxoSmithKline (GSK) ARGOS (ARGS) Telaprevir Zerenex Sequenom (SQNM) ZALTRAP™ Theravance Bio Pharma (TBPH) Incyte (INCY) SYNTA (SNTA) Valeant Pharmaceuticals International (VRX) JUNO (JUNO) Alder Biopharmaceuticals (ALDR) Ocular Therapeutix (OCUL) ADVENTRIX (ANX) Editas (EDIT) Elan (ELN) Galena (GALE) Exelixis (EXEL) PORTOLA (PTLA) Anadys (ANDS) CEMPRA (CEMP) Anacor (ANAC) ImmunoGen (IMGN) KERYX (KERX) NOVOCURE (NVCR) PTC Therapeutics (PTCT) SUNESIS PHARMACEUTICALS (SNSS) CRISPR Therapeutics (CRSP) IDERA (IDRA) Herceptin TOKAI (TKAOI) Bellicum (BLCM) BIOMARIN (BMRN) Advaxis (ADXS) Human Genome Sciences (HGSI) Sarepta (SRPT) Velcade (bortezomib)